Papers

Research literature with structured metadata.

Trials

Registered studies by status, phase, and compound.

Topics

Indications and themes psychedelics are researched for.

Compounds

Evidence across molecules with rich data.

Countries

Regulation, access, and research activity by region.

Stakeholders

Organizations shaping the space across research, policy, and funding.

People

Investigators, clinicians, and authors with mapped output.

Courses

Training programs and certifications across modalities.

Events

Conferences, workshops, and convenings by date and focus.

Results

Compare outcome data across trials and publications.

Research recaps

Monthly evidence summaries with key takeaways.

Map of research

Landscape view of trials, compounds, and outcomes.

Newsletter

Weekly or daily updates on trials, publications, analysis, and more.

Research Groups

Worldwide map of psychedelic research centres by region.

Road to Access

Science, regulation, and economics on the path to patient access.

Research Network

Interactive co-authorship map of psychedelic researchers.

Top papers

Find needles in the haystack of psychedelic research per topic.

Pricing
Back to Stakeholders
Research, Drug Development & ManufacturingAcademic & Non-Profit ResearchUniversities and Colleges with Dedicated Psychedelic Research Groups
Research, Drug Development & ManufacturingAcademic & Non-Profit Research
Research, Drug Development & Manufacturing

University of Sydney

Australia
4 Trials

The Brain and Mind Centre is advancing psychedelic science with a multidisciplinary focus on developing innovative treatments using AI and preparing for human clinical trials to treat severe mental illness.

Academic Research

0 papers

Published Papers

0

Trial Involvement

4

Distinct Focus Topics

0

Latest Publication

Unknown

Quick Facts

Type
academic
HQ
Australia
Website
Visit

Sponsored Trials

2
Not yet recruitingII

Psilocybin-assisted Therapy for Alcohol Use Disorder

Start Date
September 1, 2024
Compounds
Psilocybin, Placebo
RecruitingII

MDMA-assisted Prolonged Exposure Therapy for Comorbid Alcohol Use Disorder and Post-traumatic Stress Disorder (MPATHY)

Start Date
September 19, 2023
Compounds
MDMA, Placebo

Collaborated Trials

2
Not yet recruitingI, II

Ketamine-Enhanced Therapy for Individuals With Alcohol Use Disorder and Depression: A Pilot Study (KET-DUAL)

Start Date
December 10, 2025
Compounds
Ketamine
CompletedI

Ketamine Trial for the Treatment of Depression

Start Date
January 3, 2015
Compounds
Ketamine, Placebo

The intelligence layer for psychedelic research.

Company

  • About
  • Contact
  • Newsletter

Product

  • Feedback
  • Roadmap
  • Changelog
  • API
  • Partners

Legal

  • Privacy
  • Terms

© 2026 Blossom. All rights reserved.